The Senate Finance Committee released a new bipartisan draft legislation on Friday morning that would incentivize generic manufacturers and healthcare providers, like hospitals and clinics, to mitigate generic drug shortages by prioritizing drug quality and transparency.
“It is unacceptable that America is consistently running out of affordable and essential generic medicines,” Committee Chair Ron Wyden (D-OR) said in a statement. He singled out “monopolistic middlemen that have put market power and profit over families’ health care.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.